Status: Not yet recruiting
Observational Study of RHINOSEDAL in Acute Nasal Obstruction
This prospective, multicenter, national, observational, non-interventional post-market clinical follow-up study evaluates the performance and safety of RHINOSEDAL in children and adults presenting with acute nasal obstruction associated with common cold, allergic or non-allergic rhinitis, or rhinosinusitis. Patients prescribed RHINOSEDAL in routine care will be followed for 6 ±1 days using patient-reported outcome measures including the NOSE score.
Participants needed: 126
Trial details
Age: 8+Biological sex: AllType: ObservationalSponsor: Laboratoires ElerteUpdated: Jun 2, 2026Locations: 1
Eligibility criteria
Age 8 years or older. [+6]
Known anatomical cause of chronic nasal congestion. [+8]